ACTR1Ahas pleiotropic effects on risk of leprosy, inflammatory bowel disease and atopy
Authors: Gilchrist James J , Auckland Kathryn , Parks Tom , Mentzer Alexander J , Goldblatt Lily , Naranbhai Vivek , Band Gavin , Rockett Kirk A , Toure Ousmane B , Konate Salimata , Sissoko Sibiri , Djimdé Abdoulaye A , Thera Mahamadou A , Doumbo Ogobara K , Sow Samba , Floyd Sian , Pönnighaus Jörg M , Warndorff David K , Crampin Amelia C , Fine Paul EM , Fairfax Benjamin P , Hill Adrian VS 
Published: February 2022

Leprosy is a chronic infection of the skin and peripheral nerves caused byMycobacterium leprae. Despite recent improvements in disease control, leprosy remains an important cause of infectious disability globally. Large-scale genetic association studies in Chinese, Vietnamese and Indian populations have identified over 30 susceptibility loci for leprosy. There is a significant burden of leprosy in Africa, however it is uncertain whether the findings of published genetic association studies are generalizable to African populations. To address this, we conducted a genome-wide association study (GWAS) of leprosy in Malawian (327 cases, 436 controls) and Malian (247 cases, 368 controls) individuals. In that analysis, we replicated five risk loci previously reported in China, Vietnam and India; MHC Class I and II,LACC1(2 independent loci) andSLC29A3. We further identified a novel leprosy susceptibility locus at 10q24 (rs2015583: combinedp= 8.81 × 10−9;OR= 0.51 [95% CI 0.40-0.64]). The leprosy risk locus is a determinant ofACTR1ARNA expression in CD4+T cells (posterior probability of colocalization -PP= 0.96). Furthermore, it demonstrates pleiotropy with established risk loci for inflammatory bowel disease and atopic disease. ReducedACTR1Aexpression decreases susceptibility to leprosy and atopy but increases risk of inflammatory bowel disease. A shared genetic architecture for leprosy and inflammatory bowel disease has been previously described. We expand on this, strengthening the evidence that selection pressure driven by leprosy has shaped the evolution of autoimmune and atopic disease in modern populations. More broadly, our data highlights the importance of defining the genetic architecture of disease across genetically diverse populations, and that disease insights derived from GWAS in one population may not translate to all affected populations.

Author Summary

Leprosy remains a leading cause of infectious disability globally. Human genetic variation is a major determinant of susceptibility to infection, including leprosy. Large-scale genetic association studies have been pivotal in advancing our understanding of leprosy biology. These studies have been performed in Chinese, Vietnamese and Indian populations, and it remains unclear whether these insights are informative of leprosy susceptibility in African populations. To address this, we performed a genome-wide association study of leprosy susceptibility in Malawi and Mali. In doing so we replicate known leprosy susceptibility loci at MHC class I and II,LACC1andSLC29A3. Furthermore, we identify a novel leprosy susceptibility locus, which modifies expression ofACTR1Ain CD4+T cells and demonstrates pleiotropy with inflammatory bowel disease (IBD) and atopic disease. These data deepen our understanding of leprosy biology, identifyingACTR1Aexpression in CD4+T cells as a determinant of leprosy disease risk, and further define the role of this ancient pathogen in the evolution of immune-mediated diseases in modern populations.